Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

EVAXION BIOTECH A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark XBRLDenmarkIFRS Analyst: XBRLDenmarkIFRS

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.2%   Bankruptcy risk   7.2% 0.0% 6.0% 4.6% 4.6% 4.1% 19.1% 15.9%   Credit score (0-100)   36 0 40 46 45 48 6 12   Credit rating   BBB N/A BBB BBB BBB BBB B BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -4,454 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBITDA   -12,596 0.0 -72,649 -92,847 -183,407 -180,483 0.0 0.0   EBIT   -13,162 0.0 -72,649 -92,847 -183,407 -180,483 0.0 0.0   Pre-tax profit (PTP)   -13,234.7 0.0 -80,342.0 -103,418.0 -160,415.0 -169,792.0 0.0 0.0   Net earnings   -10,370.6 0.0 -74,842.0 -97,918.0 -154,885.0 -164,292.0 0.0 0.0   Pre-tax profit without non-rec. items   -13,235 0.0 -80,352 -103,418 -160,415 -169,792 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   129 0.0 676 1,327 33,941 32,601 0.0 0.0   Shareholders equity total   15,841 0.0 62,499 42,615 212,818 57,888 -489,598 -489,598   Interest-bearing liabilities   0.0 0.0 0.0 0.0 7,826 60,561 489,598 489,598   Balance sheet total (assets)   17,310 0.0 73,996 70,493 263,012 150,437 0.0 0.0   Net Debt   -2,905 0.0 -63,814 -34,758 -201,815 -24,676 489,598 489,598     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -4,454 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Gross profit growth   -490.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employees   13 0 0 0 0 59 0 0   Employee growth %   44.4% -100.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   17,310 0 73,996 70,493 263,012 150,437 0 0   Balance sheet change%   49.4% -100.0% 0.0% -4.7% 273.1% -42.8% -100.0% 0.0%   Added value   -12,596.5 0.0 -72,649.0 -92,847.0 -183,407.0 -180,483.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -669 -839 676 1,259 28,013 1,194 -25,082 -6,060   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 0.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   295.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -91.0% 0.0% -97.6% -141.2% -94.5% -76.9% 0.0% 0.0%   ROI %   -101.6% 0.0% -115.6% -194.1% -113.1% -86.1% 0.0% 0.0%   ROE %   -80.1% 0.0% -119.7% -186.3% -121.3% -121.4% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   91.5% 0.0% 84.5% 60.5% 80.6% 38.2% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   23.1% 0.0% 87.8% 37.4% 110.0% 13.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 3.7% 104.6% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 72.2% 31.8% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   11.1 0.0 6.4 2.2 8.0 4.8 0.0 0.0   Current Ratio   11.1 0.0 6.4 2.2 8.0 4.8 0.0 0.0   Cash and cash equivalent   2,905.0 0.0 63,814.0 34,758.0 209,641.0 85,237.0 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   14,805.0 0.0 61,653.0 32,186.0 194,749.0 87,585.0 -244,799.0 -244,799.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -969 0 0 0 0 -3,059 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -969 0 0 0 0 -3,059 0 0   EBIT / employee   -1,012 0 0 0 0 -3,059 0 0   Net earnings / employee   -798 0 0 0 0 -2,785 0 0